Drug Shortage Report for STATEX-SUPPOSITORIES 10MG
| Report ID | 19852 |
| Drug Identification Number | 00632201 |
| Brand name | STATEX-SUPPOSITORIES 10MG |
| Common or Proper name | Statex |
| Company Name | PALADIN LABS INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | MORPHINE SULFATE |
| Strength(s) | 10MG |
| Dosage form(s) | SUPPOSITORY |
| Route of administration | RECTAL |
| Packaging size | Box of 10 |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-01-07 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2021-01-08 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 SAINT-LAURENT, QUEBEC CANADA H4M 2P2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.